VASCUDYNE Trademark

Trademark Overview

On Thursday, March 14, 2024, a trademark application was filed for VASCUDYNE with the United States Patent and Trademark Office. The USPTO has given the VASCUDYNE trademark a serial number of 98449022. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, January 2, 2025. This trademark is owned by Vascudyne, Inc.. The VASCUDYNE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts

Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters

Scientific research and development; biomedical research and development
vascudyne

General Information

Serial Number98449022
Word MarkVASCUDYNE
Filing DateThursday, March 14, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, January 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAgents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts
Goods and ServicesSurgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters
Goods and ServicesScientific research and development; biomedical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code042
First Use Anywhere DateTuesday, August 11, 2020
First Use In Commerce DateTuesday, August 11, 2020

Trademark Owner History

Party NameVascudyne, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55107

Trademark Events

Event DateEvent Description
Thursday, March 14, 2024NEW APPLICATION ENTERED
Tuesday, August 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED
Monday, December 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025LETTER OF SUSPENSION E-MAILED
Thursday, January 2, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 2, 2025SUSPENSION LETTER WRITTEN
Tuesday, September 24, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NON-FINAL ACTION WRITTEN

Related Keywords

vascudyne tissue medical valves apparatus cardiovascular namely cardiac surgical biological sheets